Bulletin Contents
Search
Home Page
 
*Cotinga Pharmaceuticals Inc 
Listed Company 

CRITICAL OUTCOME TECHNOLOGIES INC. ("COT")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: March 3, 2015
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced February 18, 2015:

Number of Shares: 2,129,374 shares

Purchase Price: $0.255 per share

Warrants: 2,129,374 share purchase warrants to purchase 2,129,374 shares

Warrant Exercise Price: $0.38 for a five year period

Number of Placees: 13 Placees

Insider / Pro Group Participation:

Insider=Y /
Name ProGroup=P # of Shares
Aggregate Pro Group Involvement P 148,000
[1 Placee]

Finder's Fee: An aggregate of $41,399.23, plus 162,350 compensation warrants, each exercisable into one common share at a price of $0.29 for a period of five years, payable to Canaccord Genuity Corp., Industrial Alliance Securities Inc., TD Waterhouse Canada Inc., Felix Cirelli, Marco Durante and Mackie Research Capital Corporation.

Pursuant to Corporate Finance Policy 4.1, Section 1.11(d), the Company has issued a news release announcing the closing of the private placement and setting out the expiry dates of the hold period(s).
________________________________________